Abstract
Endometrial carcinoma remains the most common malignancy in the USA. Although predominantly occurring in the affluent postmenopausal patient of low parity, premenopausal patients in their twenties have been diagnosed with endometrial carcinoma. It is imperative that patients be evaluated when presenting with postmenopausal bleeding, postmenopausal pyometria, abnormal pap smears with histiocytes and dysfunctional uterine bleeding. These are all symptoms that may herald the presence of an endometrial carcinoma. Additional risk factors for endometrial carcinoma include: menopause occurring after age fifty-two; premenopausal women with anovulatory cycles; postmenopausal women on exogenous estrogen or Tamoxifen; and obese women with a family history of endometrial, breast, bowel, or ovarian carcinoma. Other risk factors include age, obesity, nulliparity, late menopause, hypertension, diabetes, prior exposure to radiation, feminizing ovarian tumors and Stein-Levinthal Syndrome.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have